Identification of Leishmania infantum Epidemiology, Drug Resistance and Pathogenicity Biomarkers with Nanopore Sequencing
Authors:
- Joan Martí-CarrerasJMJoan Martí-Carreras
- Marina CarrascoMCMarina Carrasco
- Marcel Gómez-PonceMGMarcel Gómez-Ponce
- Marc Noguera-JuliánMNMarc Noguera-Julián
- Roser FisaRFRoser Fisa
- Cristina RieraCRCristina Riera
- Maria Magdalena AlcoverMAMaria Magdalena Alcover
- Xavier RouraXRXavier Roura
- Lluís FerrerLFLluís Ferrer
- Olga FrancinoOFOlga Francino
Open Access
- 14 November 2022
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 10 (11) , 2256
Abstract
The emergence of drug-resistant strains of the parasite Leishmania infantum infecting dogs and humans represents an increasing threat. L. infantum genomes are complex and unstable with extensive structural variations, ranging from aneuploidies to multiple copy number variations (CNVs). These CNVs have recently been validated as biomarkers of Leishmania concerning virulence, tissue tropism, and drug resistance. As a proof-of-concept to develop a novel diagnosis platform (LeishGenApp), four L. infantum samples from humans and dogs were nanopore sequenced. Samples were epidemiologically typed within the Mediterranean L. infantum group, identifying members of the JCP5 and non-JCP5 subgroups, using the conserved region (CR) of the maxicircle kinetoplast. Aneuploidies were frequent and heterogenous between samples, yet only chromosome 31 tetrasomy was common between all the samples. A high frequency of aneuploidies was observed for samples with long passage history (MHOM/TN/80/IPT-1), whereas fewer were detected for samples maintained in vivo (MCRI/ES/2006/CATB033). Twenty-two genes were studied to generate a genetic pharmacoresistance profile against miltefosine, allopurinol, trivalent antimonials, amphotericin, and paromomycin. MHOM/TN/80/IPT-1 and MCRI/ES/2006/CATB033 displayed a genetic profile with potential resistance against miltefosine and allopurinol. Meanwhile, MHOM/ES/2016/CATB101 and LCAN/ES/2020/CATB102 were identified as potentially resistant against paromomycin. All four samples displayed a genetic profile for resistance against trivalent antimonials. Overall, this proof-of-concept revealed the potential of nanopore sequencing and LeishGenApp for the determination of epidemiological, drug resistance, and pathogenicity biomarkers in L. infantum.Keywords
Funding Information
- Centro para el Desarrollo Tecnológico Industrial (SNEO-20211355)
- Spanish Science Ministry to develop innovative solutions to novel R&D companies (SNEO-20211355)
- Elanco España SA (SNEO-20211355)
This publication has 38 references indexed in Scilit:
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing dataBioinformatics, 2011
- Analyzing and minimizing PCR amplification bias in Illumina sequencing librariesGenome Biology, 2011
- FISH analysis reveals aneuploidy and continual generation of chromosomal mosaicism in Leishmania majorCellular Microbiology, 2010
- BLAST+: architecture and applicationsBMC Bioinformatics, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantumNucleic Acids Research, 2009
- Phospholipid Translocation and Miltefosine Potency Require Both L. donovani Miltefosine Transporter and the New Protein LdRos3 in Leishmania ParasitesJournal of Biological Chemistry, 2006
- Role of the ABC Transporter MRPA (PGPA) in Antimony Resistance in Leishmania infantum Axenic and Intracellular AmastigotesAntimicrobial Agents and Chemotherapy, 2005
- Leishmania majorLACK Antigen Is Required for Efficient Vertebrate ParasitizationJournal of Experimental Medicine, 2003